Kaplan Matthew L.

Kaplan Matthew L. is listed in filings as Director at Nuvectis Pharma, Inc.. This profile follows SEC Form 4 activity through Nov 6, 2025, including purchase activity. Recent filings connect the profile to Nuvectis Pharma, Inc. (NVCT). The current snapshot covers public activity from Jun 13, 2024 to Nov 6, 2025. Reported amounts are shown as $64.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.